The funding was arranged by West Hill Capital, whose Managing Partner, Robert Caie commented: “West Hill is delighted to be investing in CPH2 at such an exciting stage in the Company’s development. We partner with successful technology entrepreneurs and back what we believe are potentially hugely scalable businesses, that in turn can offer our investors market-leading returns. We look for an innovative product that can demonstrate a global demand and in the case of CPH2, they are operating in the hydrogen economy which is forecast to be worth $2.5 trillion by 2050”.
Clive Brook, Chairman of CPH2 added “We were very pleased with the fund-raising undertaken by West Hill, and given the early stage in our development, this is a very satisfactory outcome and created a springboard from which we can make substantial progress towards the full commercialisation of our unique, patented processes".
Brook continued “To drive this period of growth, CPH2 has appointed Andy King as its new Chief Executive Officer (CEO)”.
With experience in the power, healthcare infrastructure, automotive and aviation sectors, Andy’s remit is to drive the production and sales of the low emissions and energy storage technologies. His skills in the fields of engineering, manufacturing, sales, and finance should ensure that the company stays on track to reach key goals.
Andy commented “My responsibility as CEO is to bring CPH2’s patented next generation of membrane-free electrolysers to the wider market for the benefit of all stakeholders; our shareholders and the inhabitants of a brighter future global environment. Adoption of this safe, simple and cost-effective method of producing hydrogen, using renewable power, will accelerate progress to become carbon-free by 2050”.
With more than 30 years’ experience in business and 20 years’ growing SME’s, Andy is already making a positive impact on the CPH2 team. His strong leadership and entrepreneurial flair coupled with a no-nonsense practical approach are creating renewed enthusiasm.